Alli Antar

Dr. Alli Antar currently conducts research at Baylor College of Medicine, where the primary goal of her work is to elucidate the mechanisms whereby specific genes impact metabolism and, consequently, risk for obesity, type 2 diabetes, and cardiovascular disease. Throughout her postdoc, Dr. Antar was the recipient of grants from the NIH as well as the AHA. Prior to receiving her Ph.D. from the Department of Molecular Physiology and Biophysics at Vanderbilt University, Alli Antar won Lupus Foundation of America Student Stipend and the VUMC-NIH/CHHD Reproductive Biology Pre-doctoral Training Grant awards. As a graduate student, Dr. Antar's research focused on the role of the enzyme 11beta-hydroxysteroid dehydrogenase type 1 in modulating lipid metabolism, as well as on its expression in and potential impact on the development of thymocytes.

Alli Antar is a member of several scientific societies that are both general and specific to her field. Dr. Antar is also actively involved in supervising and training graduate and undergraduate students in the lab, as well as reviewing for several journals in her field.

American Association for the Advancement of Science, American Diabetes Association, American Heart Association, American Physiological Society, Endocrine Society, Obesity Society, Sigma Xi

Lupus Foundation of America, Nashville (Mid-South) Chapter, Student Stipend Award;
VUMC-NICHD Reproductive Biology Pre-doctoral Training Grant Award; BCM-NIDDK Pediatric Gastroenterology Postdoctoral Training Grant Award; CNRC-NIHCHD Postdoctoral Training Grant Award; ENDO 2010 Presidential Poster Competition Award; AHA Postdoctoral Fellowship Award

adipose tissue, atherosclerosis, automimmune disease, dyslipidemia, cancer, enzyme kinetics, glucocorticoids, inflammation, insulin resistance, metabolism, NAFLD, nuclear hormone receptors, obesity, physiology, steroid metabolism, transcription factors, type II diabetes

Alli Antar, Dr. Alli Antar, Alli Antar Ph.D., biomedical research, Baylor College of Medicine

1. AM Nuotio-Antar, AH Hasty, WJ Kovacs. Quantitation and cellular localization of 11beta-HSD1 expression in murine thymus. J Steroid Biochem Mol Biol. 2006 May; 99(2-3):93-9.

2. ML Gruen, V Saraswathi, AM Nuotio-Antar, MR Plummer, KR Coenen, AH Hasty. Plasma insulin levels predict atherosclerotic lesion burden in obese hyperlipidemic mice. Atherosclerosis. 2006 May; 186(1):54-64.

3. AM Nuotio-Antar, DL Hachey, AH Hasty. Carbenoxolone treatment attenuates symptoms of metabolic syndrome and atherogenesis in obese, hyperlipidemic mice. Am J Physiol Endocrinol Metab. 2007 Dec; 293(6): E1517-28.

4. MV Li, W Chen, RN Harmancey, AM Nuotio-Antar, M Imamura, P Saha, H Taegtmeyer, L Chan. Glucose-6-phosphate mediates activation of the carbohydrate responsive binding protein (ChREBP). Biochem Biophys Res Commun. 2010 May 7. 395(3):395-400.